Public Health Agency of Canada CORONAVIRUS HOTLINE 1-833-784-4397

Facebook  Twitter  LinkedIn  youtube

Members Area
Resources Resources Open
Chapters Chapters Close
Site Map Site Map Open
Back to News
PIDAC: Evidence Review and Revised Recommendations for the Control of Vancomycin-Resistant Enterococci (VRE).

The Provincial Infectious Diseases Advisory Committee on Infection, Prevention and Control (PIDAC-IPC) has updated the Evidence Review and Revised Recommendations for the Control of Vancomycin-Resistant Enterococci (VRE). The document was updated to capture recent research on the impact of VRE control in health care settings. Recommendations include:

1. screening, on admission, for  risk factors and testing for VRE if risk factors are present.

2. using Contact Precautions for those who test positive for VRE  as outlined in Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) annexed to: Routine Practices and Additional Precautions in All Health Care Settings.

An Executive Summary is also available.
 
For more information on VRE visit the PHO website , contact your Regional IPAC Support team or email pidac@oahpp.ca